Austrian Myeloid Registry
Arbeitsgemeinschaft medikamentoese Tumortherapie
3,000 participants
Jul 13, 2020
OBSERVATIONAL
Conditions
Summary
The Austrian Myeloid Registry (aMYELOIDr) is a non-interventional study. It collects data from patients with the myeloid diseases, primarily myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).The aMYELOIDr is multi-center database collecting data at various sites in Austria and potentially also at other centers in other countries in future. The registry has an electronic case report form (eCRF), where all data is entered by clinical trial personnel and/or physicians. It is set up to collect real-world experience in the management of patients with these diseases in Austria.
Eligibility
Inclusion Criteria3
- Age >17 years
- Diagnosis of myeloid disease according to WHO 2016
- Signed patient informed consent (IC)
Exclusion Criteria1
- Patient is unable or unwilling to sign IC
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Only routine clinical data, which has already been recorded in the patient's medical chart, will be documented. Any other data assessments (e.g. quality of life analyses such as EQ-5D and QLQ-C30 have been approved by the Ehtikkommission für das Bundesland Salzburg and are optional.
Locations(16)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04438889